Search results
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe Sweden-headquartered company presented the Phase II readout at the American...confirmed...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 8 hours agoIn the MCL cohort of the TRANSCEND NHL 001 trial...received two to four prior lines of therapy....
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoThe vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a...
Think about planting a meadowscape in place of some grass
Gannett via AOL· 11 hours agoFarmers can assess plant survival by examining the color of the growing point of the seedlings,...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 2 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
KOLR - KSFX Ozarks· 3 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 1 day agoThe treatment, called Krazati, was little better than standard chemotherapy in a study enrolling...Oncology meeting. Patients who received Bristol’s pill lived a median of 5.5 months before ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoU.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire TOKYO, May 30, 2024 If approved, the investigational therapy would offer a new treatment option for patients with
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoProgression-free survival is how long patients live before their cancer worsens. The company added...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters via Yahoo News· 5 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...